Experimental Drug Could Be Big Advance Against Kidney Disease
TUESDAY, Dec. 19, 2023 (HealthDay News) — Early results from a trial of a new kidney disease medication show it significantly reduces levels of a urine marker of kidney damage. The experimental drug — called BI 690517 for now — cut levels of the liver protein albumin in the urineContinue Reading